Rigel Pharmaceuticals RIGL Insider Ownership

NASDAQ RIGL

$48.11 +1.39 (+2.98%)

At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

646.34K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

3.30%

▲+0.085% pp QoQ

Shares Held by Insiders

615.57K

filed for Sep 2026

▲+2.64% QoQ

Shares Outstanding

18.68Mn

18,679,864 shares

Direct Holdings

615.57K

Indirect: 0

Net Shares Traded (QoQ)

+15.84K

net buying in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Across the past 12 months, open-market trades by Rigel Pharmaceuticals insiders were all sales, totaling $305,865 (9K shares).

Rigel Pharmaceuticals' open-market sales in the past 12 months came from 2 insiders; no insider bought.
Kamil Ali-Jackson (Director) sold the most Rigel Pharmaceuticals stock on the open market over the past 12 months, $160,425 (5K shares), most recently on June 22, 2026.
Outside the open market, Rigel Pharmaceuticals insiders received 162.52K shares in stock awards, acquired 98.48K shares through option exercises and conversions and gave up 125.89K shares to cover taxes or exercise prices over the past 12 months.
Business Quant data puts insider holdings in RIGL at 615.57K shares across insiders' latest Form 4 filings, up 2.64% from 599.73K shares at the end of Q2 2026 and up 29.34% from 475.91K shares at the end of Q3 2025.
All of the 615.57K shares held by Rigel Pharmaceuticals insiders are held directly, none through trusts, partnerships or other entities.
The insider holdings in Rigel Pharmaceuticals belong to 12 insiders who have reported on Form 4 within the past two years.
Rigel Pharmaceuticals' three biggest insider holders are Raul R. Rodriguez (CEO, President, 273.36K shares), Dean L. Schorno (EVP & Chief Financial Officer, 82.96K shares) and David A. Santos (EVP, Chief Commercial Officer, 61.62K shares), based on their latest Form 4 filings.
Raul R. Rodriguez holds 44.41% of the combined insider position in Rigel Pharmaceuticals.
Institutions held 87.71% of Rigel Pharmaceuticals' outstanding shares in their Q2 2026 13F filings, insiders about 3.30% based on their latest Form 4 filings, and other investors, including the public, the remaining 8.99%.
In the past year, 12 insiders of Rigel Pharmaceuticals submitted 41 Form 4 filings reporting trades, awards or other transactions.
Insider figures for RIGL include Form 4 filings through September 3, 2026.

Form 4 Holdings

Insiders Holding RIGL

Insiders 16

Shares held 646.34K

Of outstanding 3.46%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Raul R Rodriguez	Ceo, President	273,362	273,362	42.3%	03 Sep, 2026
2	Dean L Schorno	Evp Chief Financial Officer	82,962	82,962	12.8%	03 Sep, 2026
3	David A Santos	Evp, Chief Commercial Officer	61,622	61,622	9.5%	03 Sep, 2026
4	Raymond J. Furey	Evp, Gc, Cco Corp Sec	50,559	50,559	7.8%	03 Sep, 2026
5	Alison L. Hannah	Evp, Chief Medical Officer	35,025	35,025	5.4%	10 Jul, 2026
6	Lisa Rojkjaer	Evp, Chief Medical Officer	34,003	34,003	5.3%	03 Jun, 2026
7	Walter H Moos	Director	18,472	18,472	2.9%	19 May, 2026
8	Jane Wasman	Director	18,250	18,250	2.8%	19 May, 2026
9	Anthony Gregg Lapointe	Director	18,250	18,250	2.8%	19 May, 2026
10	Kamil Ali-Jackson	Director	10,125	10,125	1.6%	24 Jun, 2026
11	Brian L. Kotzin	Director	10,000	10,000	1.5%	29 May, 2024
12	Gary A Lyons	Director	7,500	7,500	1.2%	12 Jul, 2023
13	Wolfgang Dummer	Evp Cmo	7,246	7,246	1.1%	06 Feb, 2023
14	Mark W Frohlich	Director	7,000	7,000	1.1%	19 May, 2026
15	Dolly Vance	Evp Corp. Affairs, G.C., Sect.	6,026	6,026	0.9%	26 Jan, 2022
16	Michael Patrick Miller	Director	5,937	5,937	0.9%	19 May, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

554 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
01 Sep, 2026	Raymond J. Furey	Evp, Gc, Cco Corp Sec	Disposed F	877	$47.50	$41.66K	50,559	Direct
01 Sep, 2026	Raul R Rodriguez	Ceo, President	Disposed F	2,424	$47.50	$115.14K	273,362	Direct
01 Sep, 2026	David A Santos	Evp, Chief Commercial Officer	Disposed F	874	$47.50	$41.52K	61,622	Direct
01 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Disposed F	928	$47.50	$44.08K	78,362	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Acquired M	694	$12.70	$8.81K	79,056	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Acquired M	620	$18.70	$11.59K	79,676	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Acquired M	2,000	$24.20	$48.40K	81,676	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Acquired M	1,286	$24.20	$31.12K	82,962	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Disposed M	694	$0.00	$0	12,824	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Disposed M	620	$0.00	$0	9,012	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Disposed M	2,000	$0.00	$0	7,999	Direct
02 Sep, 2026	Dean L Schorno	Evp Chief Financial Officer	Disposed M	1,286	$0.00	$0	15,867	Direct
08 Jul, 2026	Alison L. Hannah	Evp, Chief Medical Officer	Acquired A	24,400	$0.00	$0	35,025	Direct
22 Jun, 2026	Kamil Ali-Jackson	Director	Disposed S	2,500	$35.00	$87.50K	10,125	Direct
17 Jun, 2026	Raul R Rodriguez	Ceo, President	Acquired A	31,700	$0.00	$0	31,700	Direct
17 Jun, 2026	Lisa Rojkjaer	Evp, Chief Medical Officer	Acquired A	9,375	$0.00	$0	9,375	Direct
17 Jun, 2026	Raymond J. Furey	Evp, Gc, Cco Corp Sec	Acquired A	7,394	$0.00	$0	7,394	Direct
17 Jun, 2026	David A Santos	Evp, Chief Commercial Officer	Acquired A	7,394	$0.00	$0	7,394	Direct
17 Jun, 2026	Dean L Schorno	Evp Chief Financial Officer	Acquired A	7,394	$0.00	$0	7,394	Direct
17 Jun, 2026	Lisa Rojkjaer	Evp, Chief Medical Officer	Acquired A	7,394	$0.00	$0	7,394	Direct

Showing 1 to 20 of 554 transactions